BRCA1 and breast carcinoma: BRCA1/2 penetrance rates are high; results from prospective analysis of EMBRACE trial were recently reported and showed that the average cumulative risks, by age 70 years, for BRCA1 carriers were estimated to be 60% for breast cancer, 59% for ovarian cancer, and 83% for contralateral breast cancer.